Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 22. September 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9081  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 181608  
   
Cabozantinib After Immunotherapy in Advanced Renal Cell Carcinoma. The CARE Study by the Hellenic Gu Cancer Group.
Cancer Manag Res
Bamias A, Liontos M, Binas I, Stefanou D, Tzannis K, Zakopoulou R, Dedes N, Deligiannis D, Katsiana I, Mamali A, Galari M, Kakogianni K, Nikolaidou V, Ziogas DC, Moulavasilis N, Magoula V, Giannopoulou E, Christodoulou C, Dimopoulos MA, Chrisofos M.
PMID: 42770041 [PubMed]


Nanorobots and Exosomes: Driving the New Frontier for Bladder Tumors through Non-Coding RNAs.
Oncol Res
Spirito L, Quintavalle C, Coppola P, Esposito M, Esposito F, De Vita G, Pallante P.
PMID: 42769902 [PubMed - indexed for MEDLINE]


Comparison of Neoadjuvant Chemotherapy, Chemoimmunotherapy, and Upfront Radical Cystectomy in High-Risk Bladder Cancer: A Single-Center Retrospective Study.
Oncol Res
Chen S, Gan X, Lv P, Meng Q, Lin X, Zhang Q.
PMID: 42769886 [PubMed - indexed for MEDLINE]


Bladder Cancer Biomarkers: Recent Advances in Early Detection, Treatment Prediction, and Prognosis.
Oncol Res
Bai Z, Song X, Sun J, Xiao W, Meng X, Dong W.
PMID: 42769802 [PubMed - indexed for MEDLINE]


Immunotherapy in Bellini Duct Carcinoma: A Systematic Review.
Oncol Res
Lázaro-Sánchez AD, Benítez-Fuentes JD, Wikström-Fernández S, Nevado-Rodríguez M, Conesa-Zamora P, Luengo-Gil G, Ivars-Rubio A, Zafra-Poves M, Carosella ED, Fernández-Molina B, Nieto-Olivares A, Sánchez de Las Matas Garre MJ, Arroyo AB.
PMID: 42769789 [PubMed - indexed for MEDLINE]


Programmed Cell Death in Urological Cancers: Orchestrating the Immune Microenvironment and Immunotherapy.
Oncol Res
Ye Z, Luo J, Zhang Y, Lu L, Lei M, Deng S.
PMID: 42769782 [PubMed - indexed for MEDLINE]


Complement tumor-crosstalk: the role of C5a receptors in urothelial carcinomas.
Front Immunol
Lütje LS, Gruner C, Karsten CM, Merseburger AS, Roesch MC.
PMID: 42769490 [PubMed - indexed for MEDLINE]


Changes in circulating immune cells and cytokines after high-intensity aerobic exercise in patients with prostate cancer undergoing active surveillance from the ERASE randomized controlled trial.
Front Immunol
Kang DW, Patel D, Field CJ, Boulé NG, Fairey AS, Schadler KL, Courneya KS.
PMID: 42769245 [PubMed - indexed for MEDLINE]


Information and Education Needs in Prostate Cancer Care in Western Guangxi, China: A Single-Center Cross-Sectional Study.
J Multidiscip Healthc
Cao J, He C, Ji J, Cao N, Peng X, Huang L.
PMID: 42769111 [PubMed]


Long-Term or Recurrent Antibiotic Use During Childhood or Adolescence and the Risk of Kidney Cancer: A Cohort Study.
Cancer Med
Liu J, Chen X, Jia L, Jing X, Pan X, Zhang X, Jing Z, Yuan J, He Q, Dai X.
PMID: 42768754 [PubMed - indexed for MEDLINE]


Heterotopic prostatic tissue mimicking prostate cancer: the decisive role of multiparametric MRI.
BMJ Case Rep
Pedde M, Solinas E, Masala S, Scaglione M, Amadu AM.
PMID: 42767790 [PubMed - indexed for MEDLINE]


Phase 1 study of KHK2455, a long-acting, potent and selective IDO1 inhibitor, in combination with avelumab in patients with locally advanced or metastatic urothelial carcinoma.
J Immunother Cancer
Zakharia Y, de Spéville BD, Morales-Barrera R, Moreno I, Kilari D, Peguero J, Rao S, Shiue LH, Kanda H, Liu Y, Arora P, Vuppugalla R, Rodriguez-Vida A.
PMID: 42767768 [PubMed - indexed for MEDLINE]


Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection.
Cell Genom
Cheng N, Ouellette TW, Skead K, Singhawansa A, Elliott M, Cescon DW, Bratman SV, De Carvalho DD, Soave D, Awadalla P.
PMID: 42767223 [PubMed - as supplied by publisher]


Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial.
PLoS One
Merrick S, South A, Frangou E, Rush HL, Patel G, Thompson J, Plant H, Pickering L, Langley RE, Gilbert DC, Powles T, Larkin J, Meade A.
PMID: 42766600 [PubMed - indexed for MEDLINE]


Recent advances in hormone-based biopharmaceuticals for cancer therapy.
J Egypt Natl Canc Inst
Sarifulnazwan SN, Mohd Tajuddin NAF, Mohd Nasaruddin SNN, Muhammad Mukmin NMI, Engku Abdul Malik ESNS, Taher M, Susanti D, Khotib J, Faiyazuddin M, Widodo RT, Haris MS, Budiman H.
PMID: 42766044 [PubMed - indexed for MEDLINE]


Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.
Int J Urol
Miyajima K, Yanagisawa T, Fukuokaya W, Sakakibara R, Uchida N, Miszczyk M, Inoue S, Matsukawa A, Urabe F, Mori K, Fujita N, Narita S, Hatakeyama S, Habuchi T, Shariat SF, Kimura T, JHA Collaborative Group.
PMID: 42765507 [PubMed - indexed for MEDLINE]


Task-agnostic explainable contrastive learning model for malignant cell detection in urine cytology.
Biomed Phys Eng Express
N P AM, Iyer RS, N PP, B JP, Dey P.
PMID: 42765133 [PubMed - indexed for MEDLINE]


Emerging Patterns of Kidney Cancer in Young Adults: Where Do We Stand? Emerging Patterns of Kidney Cancer in Young Adults: Where Do We Stand?
Crit Rev Oncol Hematol
Troisi P, Occhipinti D, Ligato C, Sardaro V, Campi R, Merenda E, Cappoli N, Arduini D, Messina G, Di Leo D, Neri A, Rossi F, Moosavi SK, Russo P, Foschi N, Sighinolfi C, Pierconti F, Rocco B, Tortora G, Ciccarese C, Iacovelli R.
PMID: 42764100 [PubMed - as supplied by publisher]


Current Management and Investigational Therapeutic Strategies in Penile Squamous Cell Carcinoma: A Narrative Review.
Crit Rev Oncol Hematol
Lobianco L, Calvanese G, D'Alessio C, Passaro F, Passarelli A, Ventriglia J, Cecere SC, Rossetti S, Pisano C, Tambaro R, Napoli MD, Contieri R, Aveta A, Perri E, Pacifico G, Lamia MR, Coppola E, Tarotto L, Feroce F, Sepe F, Perasole G, Troiani T, Pignata S.
PMID: 42764099 [PubMed - as supplied by publisher]


Clinical Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) on Staging, Biochemical Recurrence Detection, and Treatment Decision-Making in Prostate Cancer.
Cureus
Aad S, Houmani R, Houmani J, Saad C, Sassounian H, Daouk L, Karam C, Houmani M.
PMID: 42763717 [PubMed]


   
   Artikel 1 - 20 / 181608    Seite 1 von 9081  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1